Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
96.24
-1.68 (-1.72%)
Jan 21, 2025, 4:01 PM EST - Market closed
Merck & Co. Employees
Merck & Co. had 72,000 employees as of December 31, 2023. The number of employees increased by 3,000 or 4.35% compared to the previous year.
Employees
72,000
Change (1Y)
3,000
Growth (1Y)
4.35%
Revenue / Employee
$877,417
Profits / Employee
$168,722
Market Cap
243.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 72,000 | 3,000 | 4.35% |
Dec 31, 2022 | 69,000 | 1,000 | 1.47% |
Dec 31, 2021 | 68,000 | -6,000 | -8.11% |
Dec 31, 2020 | 74,000 | 3,000 | 4.23% |
Dec 31, 2019 | 71,000 | 2,000 | 2.90% |
Dec 31, 2018 | 69,000 | 0 | - |
Dec 31, 2017 | 69,000 | 1,000 | 1.47% |
Dec 31, 2016 | 68,000 | 0 | - |
Dec 31, 2015 | 68,000 | -2,000 | -2.86% |
Dec 31, 2014 | 70,000 | -6,000 | -7.89% |
Dec 31, 2013 | 76,000 | -7,000 | -8.43% |
Dec 31, 2012 | 83,000 | -3,000 | -3.49% |
Dec 31, 2011 | 86,000 | -8,000 | -8.51% |
Dec 31, 2010 | 94,000 | -6,000 | -6.00% |
Dec 31, 2009 | 100,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Novo Nordisk | 64,319 |
Danaher | 63,000 |
MRK News
- 1 day ago - Merck: 3x Pipeline And Undervaluation Make It A Buy - Seeking Alpha
- 1 day ago - High-Quality Dividend Growth Stocks Near 52-Week Lows: Merck Is Magnificent - Seeking Alpha
- 3 days ago - Exclusive: Kennedy played key role in vaccine case against Merck - Reuters
- 4 days ago - What's In Store For Merck Stock In 2025? - Forbes
- 5 days ago - Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 - Business Wire
- 7 days ago - Jim Cramer says he supports healthcare stocks for their long-term value - CNBC
- 7 days ago - Merck CEO talks medicines beyond the company's top cancer drug - CNBC
- 7 days ago - Merck & Co. Inc. (MRK) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) - Seeking Alpha